Amino acid deprivation in cancer cells with compensatory autophagy induction increases sensitivity to autophagy inhibitors

• Published in: Molecular & cellular oncology 2024-12, Vol.11 (1), p.2377404
• Main Authors: Fukui, Takahito, Yabumoto, Manami, Nishida, Misuzu, Hirokawa, Shiori, Sato, Riho, Kurisu, Taichi, Nakai, Miyu, Hassan, Md. Abul, Kishimoto, Koji
• Format: Article
• Language: English
• Subjects: Amino acid deprivation; amino acid transporter; autophagy; cancer; chemoresistance
• ISSN: 2372-3556; 2372-3556
• DOI: 10.1080/23723556.2024.2377404

Inhibition of autophagy is an important strategy in cancer therapy. However, prolonged inhibition of certain autophagies in established cancer cells may increase therapeutic resistance, though the underlying mechanisms of its induction and enhancement remain unclear. This study sought to elucidate the mechanisms of therapeutic resistance through repeated autophagy inhibition and amino acid deprivation (AD) in an in vitro model of in vivo chronic nutrient deprivation associated with cancer cell treatment. In the human cervical cancer cell line HeLa and human breast cancer cell line MCF-7, initial extracellular AD induced the immediate expression of endosomal microautophagy (eMI). However, repeated inhibition of eMI with U18666A and extracellular AD induced macroautophagy (MA) to compensate for reduced eMI, simultaneously decreasing cytotoxicity. Here, hyperphosphorylated JNK was transformed into a hypophosphorylated state, suggesting conversion of the cell death signal to a survival signal. In a nutrient medium, cell death could not be induced by MA inhibition. However, since LAT1 inhibitors induce intracellular AD, combining them with MA and eMI inhibitors successfully promoted cell death in resistant cells. Our study identified a novel therapeuic approach for promoting cell death and addressing therapeutic resistance in cancers under autophagy-inhibitor treatment.